İki uçlu bozukluklu bir hastada triheksifenidil ile tetiklenen hipomani Düzenli düşük doz klorpromazin kullanımı sonrasında gelişen bir tardiv diskinezi olgusu bildirmekteyiz. Olgudaki tardiv diskinezinin tedavisinde antikolinerjik bir ajan olan triheksifenidil (THX) kullanıldı. Tedavi yanıtı iyi olmakla beraber, THX kullanımı sonrasında kısa süreli hipomanik dönemler görüldü. Hastanın uzun süredir düzenli tedavi altında ve belirtisiz olduğu dikkate alındığında, tedaviye eklenen THX'in hastalık seyrini olumsuz etkilediğinden ya da hipomaniyi tetiklemiş olabileceğinden şüphelendik. Söz konusu hipomanik dönemler kısa süreli idi ve olanzapin kullanımı ile kontrol altına alındı. THX dozunu artırdığımızda ise hastanın mizacında yükselme olduğunu saptadık. Ailesinde iki uçlu bozukluk öyküsü olması ve iki uçlu bozukluğun erken başlangıçlı tipine sahip olması olgumuzda tardiv hareket bozukluğunun görülmesi olasılığını artırmış olan diğer etkenlerdi. THX tardiv diskinezi tedavisinde etkili bir seçenek olarak kabul edilmekle birlikte, bu ajanın iki uçlu olan hastalarda hastalık seyrinde değişikliğe yol açma olasılığı incelemeye değerdir.
Trihexyphenidyl triggered hypomania in a bipolar patient
We observed a case of tardive dyskinesia after regular use of low dose chlorpromazine. An anticholinergic agent; trihexyphenidyl (THX) was prescribed to treat the tardive dyskinesia. The treatment response was satisfactory, but brief hypomanic episodes occurred. Because the patient was symptom free for long periods of time, we suspected that THX might have had a negative effect on the course of the disease or it might have induced hypomania. The hypomanic episodes were controlled with short term use of olanzapine. When the dose of THX was further increased, elevation of mood occurred. The history of bipolar disorder in his family and having the early onset type of bipolar disorder were features of our case that made the tardive movement disorder more likely. Although THX may be an effective option in tardive dyskinesia, possible impact on the course of the disorder in bipolar patients should be considered.
INTRODUCTION
Anticholinergic agents are frequently used in the treatment of drug induced acute extrapyramidal side effects but effectiveness of these agents in tardive movement disorders is enigmatic. On the contrary, it has been suggested that antipsychotic agents may be even worsening tardive dyskinesia
We report a case of bipolar man with tardive dyskinesia.
Brief episodes of hypomania were induced by trihexyphenidyl (THX) which had been used to treat the tardive dyskinesia. mg/day was prescribed and that was not also effective.
CASE REPORT
Modest improvement in tardive dyskinesia was observed after addition of the anticholinergic agent which is trihexyphenidyl 2 mg/day. After that, his AIMS score was 12.
His treatment regimen at that time was lithium 1200mg/day, valproic acid 1000mg/day, THX 2 mg/day. After partial improvement of dyskinetic movements, an episode of hypomania occurred; he was euphoric with excessive energy so that he was sometimes singing in public buses, he was sleeping less than normal and his amount of talking was increased that could easily be seen during the interview.
This episode of hypomania subsided with addition of olanzapine 5mg/day for 10 days. In this index visit, the blood levels of mood stabilizers were in the therapeutic range (serum levels; lithium: 0.78 mmol/L, valproat: 86.12 µg/ml).
Afterwards, reserpine 0,50mg/day and chlortalidone 100 mg/day was prescribed but modest improvement was observed. 6 months later another hypomanic episode that is similar in severity to the previous one occurred. Young mania rating score was 12(serum levels; lithium: 0.51 mmol/L, valproat: 74.37 µg/ml). This episode was controlled with olanzapine 5 mg/day for 5 days and that is followed by a subsyndromal depressive episode. When THX was titrated up to 4 mg/day, a further improvement in dystonic movements was observed with spontaneous relief from the depressive symptoms, his AIMS score was 8.
His current medication is now lithium 900 mg/day, valproic acid 1000 mg/day, THX 4 mg/day, reserpine/ chlortalidone 0.50/ 100 mg/day, clonazepam 2 mg/day. If he forgets taking his medication, the dystonic movements worsen and when he takes his medication they improve again.
DISCUSSION
The patient has history of acute dystonia with haloperidole and this is relieved by substituting that agent with chlorpromazine. Tardive movements that occurred later may be speculated to be a side effect of haloperidole, but it should be noted that he hadn't been prescribed haloperidole since 1994 and tardive dyskinesia first occurred in 2008, following 7 years of symptom free treatment with chlorpromazine and lithium.
In 2001, a brief period of parkinsonism was observed after titration of chlorpromazine to 400mg/day because of hypomania, and this parkinsonian symptoms were relieved by dose reduction to 50mg/day. That might have been a sign of increasing dopamine hypersensitivity in the patient.
At that moment, when the parkinsonism had been observed, discontinuing chlorpromazine might have been more appropriate instead of dose reduction, but the evidences favoring this decision is still inadequate.
The role of lithium in this case is difficult to interpret because of the confounding results in the literature, there are evidences that lithium has potential to decrease the risk of tardive dyskinesia, but long term lithium treatment is also associated with increased tardive dyskinesia risk (3, 4) .
In our case, there is continuous lithium treatment without cessation.
Hayashi et al. (5) reported a case of tardive dystonia which is effectively treated with THX. Euphoric effects of anticholinergic agents has been known from the literature (6) but although we found reports of psychosis induced by anticholinergic agents (7) , we didn't find any cases of hypomania induced by THX. Despite he was on continuous lithium and valproate protection, THX induced hypomania. In 1983, Tollefson and Senogles (8) suggested a cholinergic role in the mechanism of lithium in mania.
The addition of THX might have a role of diminishing the
